Hutchins GD - Search Results

1

Comparison of Tracer Kinetic Models for 68Ga-PSMA-11 PET in Intermediate Risk Primary Prostate Cancer Patients.

Smith NJ, Green MA, Bahler CD, Tann M, Territo W, Smith AM, Hutchins GD. Smith NJ, et al. Among authors: hutchins gd. Res Sq [Preprint]. 2023 Nov 1:rs.3.rs-3420161. doi: 10.21203/rs.3.rs-3420161/v1. Res Sq. 2023. Update in: EJNMMI Res. 2024 Jan 10;14(1):6. doi: 10.1186/s13550-023-01066-2. PMID: 37961116 Free PMC article. Updated. Preprint.

2

Comparison of tracer kinetic models for ⁶⁸Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients.

Smith NJ, Green MA, Bahler CD, Tann M, Territo W, Smith AM, Hutchins GD. Smith NJ, et al. Among authors: hutchins gd. EJNMMI Res. 2024 Jan 10;14(1):6. doi: 10.1186/s13550-023-01066-2. EJNMMI Res. 2024. PMID: 38198060 Free PMC article.

3

A Comparison of Arterial Input Function Interpolation Methods for Patlak Plot Analysis of ⁶⁸Ga-PSMA-11 PET Prostate Cancer Studies.

Smith NJ, Newton DT, Gunderman D, Hutchins GD. Smith NJ, et al. Among authors: hutchins gd. IEEE Trans Med Imaging. 2024 Jul;43(7):2411-2419. doi: 10.1109/TMI.2024.3357799. Epub 2024 Jul 1. IEEE Trans Med Imaging. 2024. PMID: 38306263

4

Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.

Bahler CD, Tachibana I, Tann M, Collins K, Swensson JK, Green MA, Mathias CJ, Tong Y, Yong C, Boris RS, Brocken E, Hutchins GD, Sims JB, Hill DV, Smith N, Ferari C, Love H, Koch MO. Bahler CD, et al. Among authors: hutchins gd. J Urol. 2024 Aug;212(2):290-298. doi: 10.1097/JU.0000000000004032. Epub 2024 May 24. J Urol. 2024. PMID: 38785259 Clinical Trial.

5

Hybrid ¹⁸F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.

Smith NJ, Deaton TK, Territo W, Graner B, Gauger A, Snyder SE, Schulte ML, Green MA, Hutchins GD, Veronesi MC. Smith NJ, et al. Among authors: hutchins gd. J Nucl Med. 2023 Jul;64(7):1087-1092. doi: 10.2967/jnumed.122.265149. Epub 2023 Apr 28. J Nucl Med. 2023. PMID: 37116915 Free PMC article.

6

Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma.

Jackson LR, Masi MR, Selman BM, Sandusky GE, Zarrinmayeh H, Das SK, Maharjan S, Wang N, Zheng QH, Pollok KE, Snyder SE, Sun PZ, Hutchins GD, Butch ER, Veronesi MC. Jackson LR, et al. Among authors: hutchins gd. Front Oncol. 2022 Nov 22;12:939260. doi: 10.3389/fonc.2022.939260. eCollection 2022. Front Oncol. 2022. PMID: 36483050 Free PMC article.

7

Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care.

Bahler CD, Green MA, Tann MA, Swensson JK, Collins K, Alexoff D, Kung H, Brocken E, Mathias CJ, Cheng L, Hutchins GD, Koch MO. Bahler CD, et al. Among authors: hutchins gd. Urol Oncol. 2023 Jan;41(1):48.e1-48.e9. doi: 10.1016/j.urolonc.2022.10.003. Epub 2022 Nov 1. Urol Oncol. 2023. PMID: 36333187

8

In Vivo Quantitative Whole-Body Perfusion Imaging Using Radiolabeled Copper(II) Bis(Thiosemicarbazone) Complexes and Positron Emission Tomography (PET).

Green MA, Mathias CJ, Smith NJ, Cheng M, Hutchins GD. Green MA, et al. Among authors: hutchins gd. Methods Mol Biol. 2022;2393:751-771. doi: 10.1007/978-1-0716-1803-5_40. Methods Mol Biol. 2022. PMID: 34837210

9

The Brain: Is it a Next Frontier to Better Understand the Regulation and Control of Hematopoiesis for Future Modulation and Treatment?

Broxmeyer HE, Yoder KK, Wu YC, Hutchins GD, Cooper SH, Farag SS. Broxmeyer HE, et al. Among authors: hutchins gd. Stem Cell Rev Rep. 2021 Aug;17(4):1083-1090. doi: 10.1007/s12015-021-10203-0. Epub 2021 Jul 13. Stem Cell Rev Rep. 2021. PMID: 34255283 Free PMC article.

10

Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.

Overcast WB, Davis KM, Ho CY, Hutchins GD, Green MA, Graner BD, Veronesi MC. Overcast WB, et al. Among authors: hutchins gd. Curr Oncol Rep. 2021 Feb 18;23(3):34. doi: 10.1007/s11912-021-01020-2. Curr Oncol Rep. 2021. PMID: 33599882 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters